Significant Ownership of MAVERICK CAPITAL LTD
- Notable people
- Lee Ainslie
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for MAVERICK CAPITAL LTD focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- By Maverick Capital Management, LLC - its General Partner
- Manager location
- Dallas, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow MAVERICK CAPITAL LTD with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from MAVERICK CAPITAL LTD
Significant Ownership of MAVERICK CAPITAL LTD
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | Common Stock, $0.0001 par value per share | 6.7% | $47,806,701 | +$22,029,323 | 18,970,913 | +85% | Maverick Capital, Ltd. | 31 Dec 2025 |
| WVE | Wave Life Sciences Ltd. | $0 Par Value Ordinary Shares | 5.4% | $56,093,833 | 8,261,242 | Maverick Capital, Ltd. | 31 Dec 2024 | ||
| VRNA | Verona Pharma Plc | Ordinary Shares, nominal value 0.05 GBP per share | 3.8% | $1,638,341,259 | 25,028,128 | Maverick Capital, Ltd. | 31 Dec 2024 | ||
| INFQ | Infleqtion, Inc. | Common Stock, $0.0001 par value per share | 3.6% | $107,076,081 | -$158,014,250 | 8,069,034 | -60% | Maverick Capital Management, LLC | 21 May 2026 |
| BTU | Peabody Energy Corporation | Common Stock, par value $0.01 per share | 3.3% | $137,470,447 | -$138,250,112 | 4,067,173 | -50% | Maverick Capital, Ltd. | 31 Dec 2025 |
| GUTS | Fractyl Health, Inc. | Common Stock, $0.00001 par value per share | 3.1% | $6,755,102 | 4,248,492 | Maverick Capital, Ltd. | 30 Sep 2025 | ||
| RCKT | Rocket Pharmaceuticals, Inc. | Common stock, $0.01 par value per share | 2.3% | $9,549,818 | -$22,232,671 | 2,513,110 | -70% | Maverick Capital, Ltd. | 31 Dec 2025 |
| CRIS | Curis, Inc. | Common Stock, par value $0.01 per share | 0.4% | $82,260 | -$1,048,833 | 49,554 | -93% | Maverick Capital, Ltd. | 30 Sep 2025 |
Schedules 13D/G Reported by MAVERICK CAPITAL LTD:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.